P. Murawa

15.2k total citations · 2 hit papers
47 papers, 4.1k citations indexed

About

P. Murawa is a scholar working on Surgery, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, P. Murawa has authored 47 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Surgery, 18 papers in Oncology and 14 papers in Pathology and Forensic Medicine. Recurrent topics in P. Murawa's work include Breast Cancer Treatment Studies (9 papers), Breast Lesions and Carcinomas (9 papers) and Immunotherapy and Immune Responses (5 papers). P. Murawa is often cited by papers focused on Breast Cancer Treatment Studies (9 papers), Breast Lesions and Carcinomas (9 papers) and Immunotherapy and Immune Responses (5 papers). P. Murawa collaborates with scholars based in Poland, Germany and United States. P. Murawa's co-authors include Steven Gallinger, H. Au, Malcolm J. Moore, Wendy R. Parulekar, John Hamm, Keyue Ding, Arié Figer, Daniel de Castro, David Walde and David Goldstein and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

P. Murawa

43 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

2007 2.9k citations P. Murawa et al. profile →
The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

2010 405 citations P. Murawa et al. profile →

Peers

Countries citing papers authored by P. Murawa

Since Specialization

Citations

This map shows the geographic impact of P. Murawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Murawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Murawa more than expected).

Fields of papers citing papers by P. Murawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Murawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Murawa. The network helps show where P. Murawa may publish in the future.

Co-authorship network of co-authors of P. Murawa

This figure shows the co-authorship network connecting the top 25 collaborators of P. Murawa. A scholar is included among the top collaborators of P. Murawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Murawa. P. Murawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	mRNA expression of steroidogenic enzymes, steroid hormone receptors and their coregulators in gastric cancer 2017 ·Oncology Letters ·(unknown), Dawid Murawa, Maciej Borejsza‐Wysocki, (unknown), Arkadiusz Spychała, Ryszard Marciniak, P. Murawa, Michał Drews, Paweł P. Jagodzińśki	13
2	Expression of 17β-hydroxysteroid dehydrogenase type 2 is associated with some clinicopathological features in gastric cancer 2015 ·Biomedicine & Pharmacotherapy ·(unknown), Dawid Murawa, Maciej Borejsza‐Wysocki, Ryszard Marciniak, P. Murawa, Michał Drews, Paweł P. Jagodzińśki	10
3	The pharmacokinetics of oral oxycodone in patients after total gastric resection. 2014 ·PubMed ·Edyta Szałek, (unknown), Dawid Murawa, Karol Połom, (unknown), (unknown), Tomasz Grabowski, Edmund Grześkowiak, (unknown), P. Murawa	6
4	Breast cancer: Actual methods of treatment and future trends 2014 ·Reports of Practical Oncology & Radiotherapy ·P. Murawa, Dawid Murawa, (unknown), Karol Połom	21
5	Decreased expression of ten-eleven translocation 1 protein is associated with some clinicopathological features in gastric cancer 2014 ·Biomedicine & Pharmacotherapy ·(unknown), Dawid Murawa, Maciej Borejsza‐Wysocki, Ryszard Marciniak, P. Murawa, Michał Drews, (unknown), Katarzyna Tomela, Paweł P. Jagodzińśki	28
6	The pharmacokinetics of the effervescent vs. conventional tramadol/paracetamol fixed-dose combination tablet in patients after total gastric resection 2014 ·Pharmacological Reports ·Edyta Szałek, (unknown), Dawid Murawa, Karol Połom, (unknown), Tomasz Grabowski, Anna Wolc, (unknown), Edmund Grześkowiak, Zenon J. Kokot, P. Murawa, Paweł Burchardt, (unknown)	7
7	Expression of 17β-hydroxysteroid dehydrogenase type 1 in gastric cancer 2013 ·Biomedicine & Pharmacotherapy ·(unknown), Dawid Murawa, (unknown), Ryszard Marciniak, P. Murawa, Michał Drews, Paweł P. Jagodzińśki	15
8	Flat epithelial atypia diagnosed on core needle biopsy—Clinical challenge 2012 ·Reports of Practical Oncology & Radiotherapy ·Karol Połom, Dawid Murawa, P. Murawa	5
9	Current trends and emerging future of indocyanine green usage in surgery and oncology 2011 ·Cancer ·Karol Połom, Dawid Murawa, Young Soo Rho, Piotr Nowaczyk, M. Hünerbein, P. Murawa	201
10	One hundred consecutive cases of sentinel lymph node mapping in colon cancer—the results of prospective, single-centre feasibility study with implementation of immunohistochemical staining 2011 ·International Journal of Colorectal Disease ·Dawid Murawa, Piotr Nowaczyk, M. Hünerbein, Karol Połom, Violetta Filas, J Bręborowicz, P. Murawa	9
11	Sentinel node biopsy in breast cancer using infrared laser system first experience with PDE camera 2011 ·Reports of Practical Oncology & Radiotherapy ·Karol Połom, Dawid Murawa, Michał Michalak, P. Murawa	10
12	Vacuum-assisted core-needle biopsy as a diagnostic and therapeutic method in lesions radiologically suspicious of breast fibroadenoma 2010 ·Reports of Practical Oncology & Radiotherapy ·Karol Połom, Dawid Murawa, Piotr Nowaczyk, (unknown), Elizabeth Giles, (unknown), Michał Michalak, P. Murawa	9
13	Czerniaki skóry - zasady postępowania diagnostyczno-terapeutycznego 2009 ·Nowotwory Journal of Oncology ·W. Ruka, Maciej Krzakowski, Waldemar Placek, Piotr Rutkowski, (unknown), Jacek Fijuth, Anna Nasierowska‐Guttmejer, (unknown), Lidia Rudnicka, P. Murawa, (unknown), Piotr Potemski, Renata Zaucha, Piotr J. Wysocki, (unknown), (unknown), (unknown), Wojciech Biernat, E. Towpik	4
14	The role of sentinel node biopsy in ductal carcinoma in situ of the breast 2008 ·European Journal of Surgical Oncology ·Karol Połom, Dawid Murawa, (unknown), (unknown), P. Murawa	19
15	Analysis of 5‐Methylcytosine in DNA of Breast and Colon Cancer Tissues 2007 ·IUBMB Life ·Anna‐Maria Barciszewska, Dawid Murawa, (unknown), P. Murawa, Stanisław Nowak, Mirosława Z. Barciszewska	18
16	Cases of giant Retroperitoneal Liposarcomas 2005 ·Reports of Practical Oncology & Radiotherapy ·Dawid Murawa, Ewelina Gowin, (unknown), P. Murawa	3
17	Primary leiomyosarcoma of the inferior vena cava. A case report and review of the literature 2003 ·Contemporary Oncology/Współczesna Onkologia ·(unknown), (unknown), P. Murawa, (unknown)	0
18	The stereotactic mammotomic biopsy system (SMBS) in the diagnosis of non-palpable lesions of the mammary gland 2001 ·Nowotwory Journal of Oncology ·P. Murawa, (unknown), (unknown), (unknown), (unknown)	0
19	54. Lymphatic mapping and sentinel lymphnode Biopsy in breast cancer patients in clinical stage T1-T2 NO MO 2001 ·Reports of Practical Oncology & Radiotherapy ·P. Murawa, (unknown), (unknown), (unknown), D Breborowicz, Julian Malicki	1
20	Genetically modified tumour vaccines (GMTV) in melanoma clinical trials 2000 ·Immunology Letters ·Sergiusz Nawrocki, P. Murawa, Julian Malicki, (unknown), (unknown), Dariusz Iżycki, (unknown), (unknown), (unknown), (unknown), Stefan Rose‐John, Andrzej Maćkiewicz	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact